Poly Medicure Ltd Stock Falls to 52-Week Low of Rs 1395

Stock Performance and Market Context

On the day in question, Poly Medicure’s share price fell by 6.45%, with an intraday low of Rs.1395 representing the lowest level in the past 52 weeks. This decline came amid a three-day losing streak, during which the stock has shed 11.84% of its value. The stock’s volatility was notable, with an intraday volatility of 5.26% calculated from the weighted average price, indicating heightened trading activity and uncertainty.

Poly Medicure’s performance lagged behind its sector, Medical Equipment/Supplies/Accessories, which itself declined by 5.12% on the same day. The stock underperformed the sector by 1.9%, signalling relative weakness within its peer group. Furthermore, the stock is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — underscoring a sustained downtrend.

In contrast, the broader market index, Sensex, opened flat but moved into negative territory, closing at 83,173.27 points, down 0.17% or 64.61 points. The Sensex remains 3.59% below its 52-week high of 86,159.02, with the 50-day moving average trading above the 200-day moving average, suggesting a mixed technical backdrop for the market overall.

Long-Term Underperformance

Over the past year, Poly Medicure’s stock has delivered a negative return of 42.51%, a stark contrast to the Sensex’s positive 6.59% gain and the BSE500’s 7.09% return. This divergence highlights the stock’s relative weakness and challenges in regaining investor confidence. The 52-week high for Poly Medicure was Rs.2936.7, indicating a substantial decline from its peak.

Financial Metrics and Valuation Concerns

Poly Medicure’s recent quarterly results have contributed to the subdued sentiment. The company reported a profit after tax (PAT) of Rs.75.86 crores for the quarter ended December 2025, reflecting an 11.0% decline compared to the previous period. Operating profit to net sales ratio also reached a low of 22.52%, indicating margin pressures.

Additionally, the company’s debtors turnover ratio for the half-year stood at 4.02 times, the lowest in recent periods, suggesting slower collection cycles. Despite these challenges, the company maintains a low average debt-to-equity ratio of zero, indicating a conservative capital structure.

Return on equity (ROE) remains at 12.4%, but the stock’s valuation appears stretched with a price-to-book value of 5.2 times. This valuation is considered very expensive relative to historical averages and peer comparisons. The PEG ratio of 1.9 further reflects the market’s cautious stance on the company’s growth prospects relative to its price.

Sector Position and Institutional Holdings

Poly Medicure is a significant player in the healthcare services sector, with a market capitalisation of Rs.15,202 crores, making it the second largest company in its sector behind Lenskart Solutions. It accounts for 14.53% of the sector’s market cap and contributes 15.86% of the industry’s annual sales, which total Rs.1,712.13 crores.

Institutional investors hold a substantial 23.24% stake in the company, reflecting a degree of confidence from entities with extensive analytical resources. However, the stock’s Mojo Score of 28.0 and a Mojo Grade of Strong Sell, upgraded from Sell on 28 May 2025, indicate a cautious outlook based on quantitative assessments.

Summary of Key Concerns

The stock’s recent decline to Rs.1395 marks a critical technical level, reflecting a combination of subdued earnings performance, valuation concerns, and sector-wide pressures. The company’s profitability metrics have weakened, with declining PAT and operating margins, while slower receivables turnover adds to the cautious outlook.

Despite a strong market capitalisation and significant institutional ownership, the stock’s relative underperformance compared to the Sensex and its sector peers highlights ongoing challenges. The healthcare services sector itself has experienced a downturn, with the Medical Equipment/Supplies/Accessories segment falling by over 5% on the day of the stock’s new low.

Poly Medicure’s trading below all major moving averages further emphasises the prevailing downward momentum. The stock’s valuation remains elevated relative to its fundamentals, which may be contributing to the subdued market sentiment.

Market and Sector Overview

The broader market environment has been mixed, with the Sensex hovering near its 52-week high but showing signs of short-term weakness. The healthcare services sector, while sizeable and important, has faced headwinds that have impacted stocks like Poly Medicure. The sector’s decline of 5.12% on the day of the stock’s new low underscores the challenges faced by companies in this space.

Poly Medicure’s position as a major sector constituent means its performance is closely watched, and its recent price action reflects both company-specific and sector-wide factors influencing investor sentiment.

Conclusion

Poly Medicure Ltd’s fall to a 52-week low of Rs.1395 on 6 Feb 2026 encapsulates a period of sustained underperformance amid a challenging sector environment and company-specific financial pressures. The stock’s decline over the past year, coupled with weakening profitability ratios and valuation concerns, has contributed to a cautious market stance. While the company remains a significant player in healthcare services, its current trading levels and financial metrics highlight the complexities facing the stock in the near term.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →